APP Pharmaceuticals is a fully-integrated pharmaceutical company that develops, manufactures and markets injectable pharmaceutical products with a primary focus on the oncology, anti-infective, anesthetic/analgesic and critical care markets. The company offers one of the most comprehensive product portfolios used in hospitals, long-term care facilities, alternate care sites and clinics within North America and manufactures a comprehensive range of dosage formulations. Headquartered in Schaumburg, Ill., the company has manufacturing facilities in Melrose Park, Ill., Grand Island, N.Y. and Barceloneta, P.R. APP has more than1,660 employees, who each work toward the common goal of providing operational excellence. As a result, APP is able to meet the needs of our customers, and in doing so, make a meaningful difference in patients’ lives. www.apppharma.com.